about
Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectivesChemotherapeutic xCT inhibitors sorafenib and erastin unraveled with the synaptic optogenetic function analysis toolEmerging strategies for managing differentiated thyroid cancers refractory to radioiodine.Design, Synthesis and Structure-Activity Relationships of Novel Diaryl Urea Derivatives as Potential EGFR Inhibitors.Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in the treatment of advanced thyroid cancer: a meta-analysis of randomized controlled trials.Advances in small molecule therapy for treating metastatic thyroid cancer.Breastfeeding and thyroid cancer risk in women: A dose-response meta-analysis of epidemiological studies.Current and future immunotherapies for thyroid cancer.
P2860
Q26751274-3260F8C1-B0F8-479F-AE43-3293F2C1DE6BQ38611037-80E0FC4A-DF69-4DF2-806B-1F69E8ED87D0Q38675367-65F99492-44B0-448F-BE05-BB1DA73DED2FQ38729889-225402ED-37DB-4ACA-B35C-0224729BE745Q38791974-F91A9C65-D4F0-4A74-97CF-D9D5EA8E3F52Q39364787-FBDCC46A-A1FF-4D88-BB88-4F8B3AE5872DQ40999538-89BB1E8F-488E-40B3-8625-90D90C9F58E0Q47781457-20778546-3C90-4C6B-84F9-F35A9A18CE36
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Sorafenib in the treatment of thyroid cancer.
@en
Sorafenib in the treatment of thyroid cancer.
@nl
type
label
Sorafenib in the treatment of thyroid cancer.
@en
Sorafenib in the treatment of thyroid cancer.
@nl
prefLabel
Sorafenib in the treatment of thyroid cancer.
@en
Sorafenib in the treatment of thyroid cancer.
@nl
P2093
P2860
P1476
Sorafenib in the treatment of thyroid cancer.
@en
P2093
Alessandro Antonelli
Enke Baldini
Gabriele Materazzi
Paolo Miccoli
Poupak Fallahi
Roberto Spisni
Salvatore Ulisse
Silvia Martina Ferrari
Ugo Politti
P2860
P304
P356
10.1586/14737140.2015.1064770
P577
2015-07-07T00:00:00Z